Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2.

Venkatasubba Rao CP, Suarez JI, Martin RH, Bauza C, Georgiadis A, Calvillo E, Hemphill JC 3rd, Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators.

Neurocrit Care. 2019 Sep 4. doi: 10.1007/s12028-019-00835-z. [Epub ahead of print]

PMID:
31486027
2.

In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines.

Silva AM, Alvarado HL, Abrego G, Martins-Gomes C, Garduño-Ramirez ML, García ML, Calpena AC, Souto EB.

Pharmaceutics. 2019 Jul 24;11(8). pii: E362. doi: 10.3390/pharmaceutics11080362.

3.

Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1.

Suarez JI, Martin RH, Bauza C, Georgiadis A, Venkatasubba Rao CP, Calvillo E, Hemphill JC 3rd, Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators.

Neurocrit Care. 2019 Jun 7. doi: 10.1007/s12028-019-00750-3. [Epub ahead of print]

PMID:
31175567
4.

Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders.

Rincón M, Calpena AC, Fabrega MJ, Garduño-Ramírez ML, Espina M, Rodríguez-Lagunas MJ, García ML, Abrego G.

Nanomaterials (Basel). 2018 Dec 7;8(12). pii: E1022. doi: 10.3390/nano8121022.

5.

Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain.

Rincón M, Calpena AC, Clares B, Espina M, Garduño-Ramírez ML, Rodríguez-Lagunas MJ, García ML, Abrego G.

Nanomedicine (Lond). 2018 Oct;13(19):2397-2413. doi: 10.2217/nnm-2018-0195. Epub 2018 Oct 12.

PMID:
30311846
6.

In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.

Cañadas C, Alvarado H, Calpena AC, Silva AM, Souto EB, García ML, Abrego G.

Int J Pharm. 2016 Sep 25;511(2):719-27. doi: 10.1016/j.ijpharm.2016.07.055. Epub 2016 Jul 30.

PMID:
27480398
7.

Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.

Abrego G, Alvarado H, Souto EB, Guevara B, Bellowa LH, Garduño ML, Garcia ML, Calpena AC.

Int J Pharm. 2016 Mar 30;501(1-2):350-61. doi: 10.1016/j.ijpharm.2016.01.071. Epub 2016 Feb 1.

PMID:
26844786
8.

Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.

Parra A, Clares B, Rosselló A, Garduño-Ramírez ML, Abrego G, García ML, Calpena AC.

Int J Pharm. 2016 Mar 30;501(1-2):10-7. doi: 10.1016/j.ijpharm.2016.01.056. Epub 2016 Jan 27.

PMID:
26826569
9.

Data collection and interpretation.

Citerio G, Park S, Schmidt JM, Moberg R, Suarez JI, Le Roux PD; Second Neurocritical Care Research Conference Investigators.

Neurocrit Care. 2015 Jun;22(3):360-8. doi: 10.1007/s12028-015-0139-4. Review.

PMID:
25846711
10.

Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.

Abrego G, Alvarado H, Souto EB, Guevara B, Bellowa LH, Parra A, Calpena A, Garcia ML.

Eur J Pharm Biopharm. 2015 Sep;95(Pt B):261-70. doi: 10.1016/j.ejpb.2015.01.026. Epub 2015 Feb 11.

11.

Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.

Alvarado HL, Abrego G, Garduño-Ramirez ML, Clares B, Calpena AC, García ML.

Nanomedicine. 2015 Apr;11(3):521-30. doi: 10.1016/j.nano.2015.01.004. Epub 2015 Feb 4.

PMID:
25659643
12.

Development and validation of a high-performance liquid chromatography method for the quantification of ursolic/oleanic acids mixture isolated from Plumeria obtusa.

Alvarado HL, Abrego G, Garduño-Ramirez ML, Clares B, García ML, Calpena AC.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Mar 1;983-984:111-6. doi: 10.1016/j.jchromb.2015.01.009. Epub 2015 Jan 15.

PMID:
25638028
13.

Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.

Clares B, Calpena AC, Parra A, Abrego G, Alvarado H, Fangueiro JF, Souto EB.

Int J Pharm. 2014 Oct 1;473(1-2):591-8. doi: 10.1016/j.ijpharm.2014.08.001. Epub 2014 Aug 4.

PMID:
25102113
14.

Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.

Abrego G, Alvarado HL, Egea MA, Gonzalez-Mira E, Calpena AC, Garcia ML.

J Pharm Sci. 2014 Oct;103(10):3153-64. doi: 10.1002/jps.24101. Epub 2014 Aug 4.

PMID:
25091511

Supplemental Content

Loading ...
Support Center